AGREEMENTAgreement • November 14th, 1996 • Sugen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 2.2Stock Option Agreement • June 21st, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • New York
amongAgreement and Plan of Merger • June 21st, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.58 Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. COLLABORATION AGREEMENT by...License Agreement • November 14th, 1996 • Sugen Inc • Biological products, (no disgnostic substances) • California
Annex I to Note Purchase AgreementNote Purchase Agreement • September 18th, 1997 • Sugen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.79 AGREEMENTCommon Stock Purchase Agreement • June 1st, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • California
SUGEN, INC. COMMON STOCKUnderwriting Agreement • October 24th, 1996 • Sugen Inc • Biological products, (no disgnostic substances) • New York
Annex IV to Note Purchase AgreementPurchase Agreement • September 18th, 1997 • Sugen Inc • Biological products, (no disgnostic substances) • California
Customer Number 1036 AMENDED AND RESTATED MASTER LEASE AGREEMENT Lessor: TRANSAMERICA BUSINESS CREDIT CORPORATION Riverway II West Office Tower 9399 West Higgins Road Rosemont, Illinois 60018 Lessee: SUGEN, INC. 515 Galveston Drive Redwood City,...Master Lease Agreement • March 31st, 1998 • Sugen Inc • Biological products, (no disgnostic substances) • Illinois
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SS.SS.200.80(B)(4), 200.83 AND 240.24B-2 BUILD-TO-SUIT LEASE Landlord: Britannia Pointe Grand Limited Partnership Tenant: SUGEN, Inc. Date: June 11, 1997 TABLE OF...Sugen Inc • August 14th, 1997 • Biological products, (no disgnostic substances) • California
No. WN- Right to Purchase $_________ Aggregate Principal Amount of 12% Senior Convertible Notes of SUGEN, Inc.Sugen Inc • March 29th, 1999 • Biological products, (no disgnostic substances) • California
RECITALSCollaboration Agreement • November 13th, 1998 • Sugen Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.81 CONFIDENTIAL Date: February 22, 1999 To: Stephen Evans-Freke Chairman and Chief Executive Officer cc: Susan Kanaya, Treasurer, SUGEN, Inc. Suzanne Hooper, Cooley Godward LLP From: Donald E. Nickelson Chairman of the Compensation...Sugen Inc • June 1st, 1999 • Biological products, (no disgnostic substances)
RECITALSHeads of Agreement • August 14th, 1998 • Sugen Inc • Biological products, (no disgnostic substances) • California
AMENDMENTAgreement • November 14th, 1996 • Sugen Inc • Biological products, (no disgnostic substances)
NYU/SUGENResearch and License Agreement • August 14th, 1997 • Sugen Inc • Biological products, (no disgnostic substances)
RESTRICTED STOCK BONUS AGREEMENT WITH JAMES L. KNIGHTON This Agreement is made as of the 29th day of October, 1998, by and between SUGEN, Inc., a Delaware corporation (the "Company"), and James L. Knighton ("Recipient"). Witnesseth: Whereas, Recipient...Restricted Stock Bonus Agreement • March 31st, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • California
Customer Number 1036 SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT Lessor: TRANSAMERICA BUSINESS CREDIT CORPORATION Riverway II West Office Tower 9399 West Higgins Road Rosemont, Illinois 60018 Lessee: SUGEN, INC. 230 East Grand Avenue South San...Master Lease Agreement • May 17th, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • Illinois
NOTE PURCHASE AGREEMENT DATED AS OF SEPTEMBER 8, 1997 BY AND BETWEEN SUGEN, INC.Note Purchase Agreement • September 18th, 1997 • Sugen Inc • Biological products, (no disgnostic substances) • California
SUGEN, INC.Underwriting Agreement • November 5th, 1997 • Sugen Inc • Biological products, (no disgnostic substances) • California
SECURITIES PURCHASE AND EXCHANGE AGREEMENT dated as of March 19, 1999 by and between SUGEN, INC.Securities Purchase and Exchange Agreement • March 29th, 1999 • Sugen Inc • Biological products, (no disgnostic substances) • California
EXHIBIT 10.54 Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. RESEARCH AND DEVELOPMENT...Research Collaboration Agreement • November 14th, 1996 • Sugen Inc • Biological products, (no disgnostic substances) • Massachusetts
Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. ss.ss. 200.80(b)(4), 200.83 and 240.24b-2 AMENDMENT FIRST This first amendment (the "Amendment"), dated December 31, 1998, ("Effective Date of this Amendment") entered...Sugen Inc • March 31st, 1999 • Biological products, (no disgnostic substances)
TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SS.SS.200.80(B)(4), 200.83 AND 240.24B-2 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE ("Amendment") is entered into as of March 18, 1998 between BRITANNIA...Sugen Inc • May 15th, 1998 • Biological products, (no disgnostic substances)
